SIC
WVE icon

SJS Investment Consulting’s Wave Life Sciences WVE Stock Holding History

SJS Investment Consulting’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.75K Buy
302
+249
+470% +$1.65K ﹤0.01% 1827
2026
Q1 		$385 Buy
53
+36
+212% +$469 ﹤0.01% 1829
2025
Q4 		$289 Buy
+17
New +$173 ﹤0.01% 1700

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

SJS Investment Consulting's WVE Position: Q2 2026 in Review

SJS Investment Consulting increased its Wave Life Sciences (WVE) stake by 470% in Q2 2026, buying an estimated $1.65K and bringing the position to 302 shares worth $1.75K. The position accounts for ﹤0.01% of the portfolio, ranked #1827.

SJS Investment Consulting first reported a position in WVE in Q4 2025 and has held it in 3 quarters since. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • SJS Investment Consulting held 302 shares of Wave Life Sciences worth $1.75K as of Q2 2026.
  • SJS Investment Consulting bought 249 Wave Life Sciences shares in Q2 2026, an estimated $1.65K.
  • Wave Life Sciences made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1827 holding.
  • SJS Investment Consulting first reported a position in Wave Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.